Persistent CMV viremia
Basic details
Preferred term: Persistent CMV viremia
Alt. terms:
HPO term: Persistent CMV viremia
HPO code: HP:0032247
GenIA ID: 12545
Last updated on: 2021-08-02 21:50:33
Cross ref. with other ontologies
NCIT: -
MESH: -
EFO: -
OAE: -
SNOMEDCT: -
ICD10: -
Description
Lasting (uncontrolled) presence of cytomegalovirus in the blood circulation. Note: Persistent CMV infection has important clinical relevance in the global population. Although immune-mediated control of CMV in healthy individuals prevents disease and overt clinical symptoms, immune dysregulation caused by immunosuppressive treatments in transplant and cancer patients, congenital immunodeficiencies, HIV/AIDS, and/or aging can result in CMV viremia, life threatening disease, and even death.
Hierarchical classification
Reported patients added to GenIA DB
SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
---|---|---|---|---|---|---|---|
101043 | M | 210725![]() |
- | Caucasian | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.H:II.2(30)]; PMID:34975878 [Fam.F017:P017] |
101479 | F | 210314![]() |
- | German | Cytomegalovirus infection | NFKB1 insufficiency | PMID:34975878 [Fam.F160:P160]; PMID:32278790 [Fam.BF:II.2(II.2)]; PMID:29403474 [Fam.(13):II.1(Patient 2)]; PMID:27923702 [Fam.191:II.1(Patient 2)]; PMID:150198 [Fam.AO:II.2(164)]; GRID:001142 [Fam.#:II.2(FR036)] |
101553 | M | 210256 | 33 | German | Cytomegalovirus infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F182:P182] |
101655 | F | 212630![]() |
- | Somali | Persistent CMV viremia | ARPC1B deficiency | PMID:30771411 [P5(II.2)]; PMID:35767111 [P3] |
101687 | F | 212635![]() |
- | Nepalese | Persistent CMV viremia | ARPC1B deficiency | PMID:30771411 [P12(II.1)] |
101722 | F | 210261![]() |
- | Asian | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.D:II.1(D.II.1)]; PMID:29729943 [Fam.D:II.1(D.II.1 (22))]; PMID:27418640 [P18(5)] |
101792 | M | 210991 | - | Caucasian | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.NN:II.11(NN.II.9(92))] |
101799 | M | 211120 | -,- | Caucasian | Cytomegalovirus infection,Persistent CMV viremia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [Fam.XX:II.1]; PMID:29729943 [Fam.XX:II.1(126)] |
102157 | F | 214681 | - | Caucasian | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.R:II.5(45)] |
102181 | F | 214913 | 3 | Cytomegalovirus infection | Severe combined immunodeficiency 9A, T-B- | PMID:30877075 [Case 22]; PMID:28864286 [P1]; PMID:28769923 [P34] | |
102262 | F | 214927![]() |
1 | Japanese | Cytomegalovirus infection | OAS1 immunodeficiency | PMID:29455859 [Fam.C:II.1]; PMID:34145065 [P5(II.1)]; PMID:29185156 [P2] |
102269 | M | 214928![]() |
0 | Japanese | Cytomegalovirus infection | OAS1 immunodeficiency | PMID:29455859 [Fam.A:II.3] |
102901 | F | 215008![]() |
1 | Brasilian | Cytomegalovirus infection | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:35064468 [patient(II.2)] |
102934 | F | 215035![]() |
- | Caucasian | Cytomegalovirus infection | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P23]; PMID:33464451 [P14(III.1)]; PMID:37419334 [P23(22)] |
102935 | M | 215035![]() |
- | Caucasian | Cytomegalovirus infection | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P24]; PMID:33464451 [Fam.P14:III.2(P15)]; PMID:37419334 [P15(27)] |
103076 | F | 215099![]() |
3 | Omani | Cytomegalovirus infection | Seizures, cortical blindness, microcephaly syndrome | PMID:33662367 [Fam.F5:V.5(P6)] |
103113 | M | 215100![]() |
- | Iranian | Cytomegalovirus infection | Seizures, cortical blindness, microcephaly syndrome | PMID:36212620 [Patient(II.1)] |
103462 | F | 215132![]() |
- | Moroccan | Cytomegalovirus infection | ARPC1B deficiency | PMID:35767111 [P4(II.2)] |
103473 | F | 215134![]() |
2 | French | Cytomegalovirus infection | Immunodeficiency 55 | PMID:28414293 [Fam.A:II.1(P1)]; PMID:14702466 [Fam.1:II.1(P1)] |
103478 | M | 215135![]() |
- | French | Persistent CMV viremia | Immunodeficiency 55 | PMID:28414293 [Fam.B:II.1(P3)] |
104942 | F | 215622![]() |
53 | Dutch | Persistent CMV viremia | NFKB1 insufficiency | PMID:32278790 [Fam.NA:III.18(III.18)]; PMID:26279205 [Fam.NL1:III.19(57)]; PMID:29403474 [Fam.NL1 (5):III.19(57)]; PMID:150198 [Fam.AA:III.19(045)]; PMID:35242131 [Fam.2:I.1(P2)] |
105051 | F | 215634![]() |
- | Cytomegalovirus infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:29180260 [Patient(II.1)] | |
105088 | M | 215638 | - | Japanese | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:26644313 [II.3(II.3)]; PMID:30250467 [M.II.3]; PMID:29729943 [Fam.M:II.3(M.II.3 (37))]; PMID:27418640 [P21(II.3)]; PMID:35087518 [11.1] |
105316 | U | 215691 | 35 | European | Cytomegalovirus infection | NFKB1 insufficiency | PMID:32278790 [H.II.1]; PMID:29477724 [Fam.H:II.1(II:1)]; PMID:150198 [Fam.BB:267] |
105317 | M | 215692![]() |
42 | European | Cytomegalovirus infection | NFKB1 insufficiency | PMID:32278790 [Fam.J:III.2(III.2)]; PMID:29477724 [Fam.J:III.2(III:2)]; PMID:150198 [Fam.BD:III.2(277)] |
105333 | F | 215695 | - | European | Cytomegalovirus infection | NFKB1 insufficiency | PMID:32278790 [N.II.1]; PMID:29477724 [Fam.N:II.1(II:1)]; PMID:150198 [Fam.BH:286] |
105362 | M | 215721![]() |
1 | Iraqi | Cytomegalovirus infection | Immunodeficiency 87 | PMID:31308374 [Fam.B:II.1(P3)] |
105396 | F | 215733![]() |
- | Moroccan | Cytomegalovirus infection | Immunodeficiency 87 | PMID:32562707 [Fam.1:II.4(Pt 4)] |
105481 | M | 215777![]() |
- | Haitian/Hispanic | Cytomegalovirus infection | Activated p110-delta syndrome 1 | PMID:24165795 [Fam.A:II.1(A.1)] |
105504 | F | 215783![]() |
- | Asian | Cytomegalovirus infection | Activated p110-delta syndrome 1 | PMID:24165795 [Fam.E:II.1(E.1)] |
105507 | M | 215784![]() |
- | Caucasian | Cytomegalovirus infection | Activated p110-delta syndrome 1 | PMID:24165795 [Fam.D:I.1(D.I.1)] |
105509 | M | 215784![]() |
- | Caucasian | Cytomegalovirus infection | Activated p110-delta syndrome 1 | PMID:24165795 [Fam.D:II.1(D.II.1)] |
105510 | F | 215784![]() |
- | Caucasian | Cytomegalovirus infection | Activated p110-delta syndrome 1 | PMID:24165795 [Fam.D:II.2(D.II.2)] |
105543 | M | 215797 | - | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:28983403 [P7] | |
105546 | M | 215800![]() |
- | Caucasian | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29867916 [N211(II.1)]; PMID:29729943 [Fam.O:II.1(O.II.1 (42))] |
105567 | M | 215808 | - | Turkish | Cytomegalovirus infection | Immunodeficiency, common variable, 8 | PMID:31026575 [P3]; PMID:31432443 [P12] |
105830 | M | 215887 | 4 | Polish | Cytomegalovirus infection | Activated p110-delta syndrome 1 | PMID:26437962 [Fam.2 Sporadic pati:2 Sporadic patient 2] |
105910 | F | 215905 | 51,- | Caucasian | Cytomegalovirus infection,Persistent CMV viremia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [K.II.1]; PMID:29729943 [Fam.K:II.1(K.II.1 (33))] |
106037 | M | 215925 | - | Japanese | Persistent CMV viremia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.DD:II.1(DD.II.1 (75))]; PMID:35087518 [Fam.19:II.1(19.2)] |
106047 | F | 215930 | - | Caucasian | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.LL:II.1(LL.II.1 (86))] |
106094 | M | 215947 | - | Caucasian | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.VV:II.1(VV.II.1 (124))] |
106150 | F | 215955 | - | Turkish | Cytomegalovirus infection | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:33464451 [P10] |
106390 | M | 216005 | 23 | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:32996901 [Patient(II.1)] | |
106669 | M | 216103 | - | Cytomegalovirus infection | NFKB1 insufficiency | PMID:150198 [Fam.EE:565]; PMID:35281075 [5] | |
106750 | F | 216121![]() |
0,0 | Palestinian | Cytomegalovirus infection,Persistent CMV viremia | T-negative/B-positive SCID type 1 | PMID:32921793 [Fam.B:II.1(P1-B)] |
106840 | M | 216167 | 17 | SouthEast Asian | Cytomegalovirus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:35242131 [3] |
107103 | M | 216335![]() |
- | Chinese (China) | Cytomegalovirus infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:35677041 [Pt1(II.2)] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).